结核病治疗毒性和有效性的药物遗传学在一个大型的巴西队列中
Gustavo Amorim1, James Jaworski2, Jing Yang1,3
1Vanderbilt University Medical Center, Department of Biostatistics.
Pharmacogenetics and genomics
|October 29, 2024
概括
遗传变异影响结核病药物毒性. 在巴西成年人中,NAT2缓慢的乙化剂状态增加了不良事件,而其他基因多态性显示出与毒性和治疗结果的不同关联.
科学领域:
- 药物遗传学 药物遗传学
- 结核病的治疗方法
- 药物不良反应 药物不良反应
背景情况:
- 遗传多态性与抗结核药物毒性有关.
- 了解这些关联对于个性化治疗策略至关重要.
研究的目的:
- 在巴西接受结核病治疗的成年人中调查遗传多态和不良事件 (包括肝毒性) 与治疗失败/复发之间的关联.
主要方法:
- 巴西的前性观察性研究 (RePORT-巴西),共903名参与者.
- 对20个与药物代谢和毒性相关的基因中的43个多态的分析.
- 为了深入的毒性分析,在子集中对整个外体序列进行测序.
主要成果:
- NAT2缓慢乙化剂状态与2级以上不良事件和肝毒性风险增加相关.
- GSTM1和SLCO1B1多态性与更高的不良事件和肝毒性风险有关.
- SLCO1B1和NR1/2多态表现出与治疗失败/复发的关联.
结论:
- 在巴西结核病患者中,NAT2乙化剂状态是治疗相关不良事件的重要预测因素.
- 需要对更大的队列进行进一步研究,以探索与治疗失败和复发相关的多态性.
相关概念视频
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Pulmonary Tuberculosis I
220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
Pulmonary Tuberculosis IV
134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
Pulmonary Tuberculosis III
305
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
305
Analysis of Population Pharmacokinetic Data
235
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
235
Pulmonary Tuberculosis II
212
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
212


